Back

Impact of background insulin treatment on cardiorenal outcomes in patients with type 2 diabetes: a patient-level analysis of merged CANVAS and CREDENCE trials

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (2) - Cardiometabolic and diabetes Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Martina Chiriaco

University Hospital of Pisa, Pisa (Italy)

7 More presentations in this session

Presentation thumbnail
Discussant - Cardiometabolic and diabetes
Presentation thumbnail
Incidence of ischemic heart disease according to change of metabolic syndrome
Doctor C. Park (Daegu, KR)
Abstract
Presentation thumbnail
Impact of cumulative inflammatory burden on the risk of metabolic dysfunction-associated steatotic liver disease
Professor R. Huang (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Comparison of the triglyceride-glucose index and triglyceride-HDL ratio as discriminators of metabolic syndrome in the elderly population
Doctor N. Rodriguez Medina (Bogota, CO)
Abstract Slides
Presentation thumbnail
Effect of SGLT2 inhibitor therapy on left ventricular longitudinal and circumferential strain in patients with type 2 diabetes mellitus and normal left ventricular ejection fraction.
Doctor A. Kaushik (Jodhpur, IN)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (2) - Cardiometabolic and diabetes

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Session
Repurposing anti-diabetic pharmacotherapy: the new cure for all evils?
thumbnail
Congress Session
Late-Breaking Clinical Science: cardiometabolic medicine
thumbnail
Congress Session
Improving cardiorenal outcomes in type 2 diabetes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources